187 related articles for article (PubMed ID: 23349985)
1. Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis.
Svensson MN; Andersson SE; Erlandsson MC; Jonsson IM; Ekwall AK; Andersson KM; Nilsson A; Bian L; Brisslert M; Bokarewa MI
PLoS One; 2013; 8(1):e54884. PubMed ID: 23349985
[TBL] [Abstract][Full Text] [Related]
2. Impaired signaling through the Fms-like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis.
Svensson MN; Erlandsson MC; Jonsson IM; Andersson KM; Bokarewa MI
J Leukoc Biol; 2016 Mar; 99(3):413-23. PubMed ID: 26392589
[TBL] [Abstract][Full Text] [Related]
3. FLT3/FLT3L-mediated CD103
Zhou CZ; Wang RF; Cheng DL; Zhu YJ; Cao Q; Lv WF
Biomed Pharmacother; 2019 Oct; 118():109031. PubMed ID: 31545219
[TBL] [Abstract][Full Text] [Related]
4. FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis.
Ramos MI; Perez SG; Aarrass S; Helder B; Broekstra P; Gerlag DM; Reedquist KA; Tak PP; Lebre MC
Arthritis Res Ther; 2013; 15(6):R209. PubMed ID: 24314260
[TBL] [Abstract][Full Text] [Related]
5. CD8α⁺ dendritic cells improve collagen-induced arthritis in CC chemokine receptor (CCR)-2 deficient mice.
Ibarra JM; Quinones MP; Estrada CA; Jimenez F; Martinez HG; Ahuja SS
Immunobiology; 2011 Sep; 216(9):971-8. PubMed ID: 21531476
[TBL] [Abstract][Full Text] [Related]
6. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of dendritic cells and antigen presentation.
Dehlin M; Andersson S; Erlandsson M; Brisslert M; Bokarewa M
J Leukoc Biol; 2011 Oct; 90(4):811-7. PubMed ID: 21771900
[TBL] [Abstract][Full Text] [Related]
8. Fms-like tyrosine kinase 3 ligand regulates migratory pattern and antigen uptake of lung dendritic cell subsets in a murine model of allergic airway inflammation.
Shao Z; Makinde TO; McGee HS; Wang X; Agrawal DK
J Immunol; 2009 Dec; 183(11):7531-8. PubMed ID: 19917684
[TBL] [Abstract][Full Text] [Related]
9. Absence of Fms-like tyrosine kinase 3 ligand (Flt3L) signalling protects against collagen-induced arthritis.
Ramos MI; Karpus ON; Broekstra P; Aarrass S; Jacobsen SE; Tak PP; Lebre MC
Ann Rheum Dis; 2015 Jan; 74(1):211-9. PubMed ID: 24064002
[TBL] [Abstract][Full Text] [Related]
10. Endogenous Fms-like tyrosine kinase-3 ligand levels are not altered in mice after a severe burn and infection.
Bohannon JK; Cui W; Toliver-Kinsky T
BMC Immunol; 2009 Aug; 10():47. PubMed ID: 19715582
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific suppression of established arthritis in mice by dendritic cells deficient in NF-kappaB.
Martin E; Capini C; Duggan E; Lutzky VP; Stumbles P; Pettit AR; O'Sullivan B; Thomas R
Arthritis Rheum; 2007 Jul; 56(7):2255-66. PubMed ID: 17599748
[TBL] [Abstract][Full Text] [Related]
12. Vaccination with Flt3L-induced CD8α+ dendritic cells prevents CD4+ T helper cell-mediated experimental autoimmune myocarditis.
Valaperti A; Nishii M; Germano D; Liu PP; Eriksson U
Vaccine; 2013 Oct; 31(42):4802-11. PubMed ID: 23948227
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-2 inhibits FMS-like tyrosine kinase 3 receptor ligand (flt3L)-dependent development and function of conventional and plasmacytoid dendritic cells.
Lau-Kilby AW; Kretz CC; Pechhold S; Price JD; Dorta S; Ramos H; Trinchieri G; Tarbell KV
Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2408-13. PubMed ID: 21262836
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic treatment with fms-like tyrosine kinase-3 ligand after burn injury enhances global immune responses to infection.
Bohannon J; Cui W; Cox R; Przkora R; Sherwood E; Toliver-Kinsky T
J Immunol; 2008 Mar; 180(5):3038-48. PubMed ID: 18292526
[TBL] [Abstract][Full Text] [Related]
15. Selective expansion of merocytic dendritic cells and CD8DCs confers anti-tumour effect of Fms-like tyrosine kinase 3-ligand treatment in vivo.
Hennies CM; Reboulet RA; Garcia Z; Nierkens S; Wolkers MC; Janssen EM
Clin Exp Immunol; 2011 Mar; 163(3):381-91. PubMed ID: 21235535
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity.
Liu Y; Huang H; Chen Z; Zong L; Xiang J
J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636
[TBL] [Abstract][Full Text] [Related]
17. The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis.
Tort Tarrés M; Aschenbrenner F; Maus R; Stolper J; Schuette L; Knudsen L; Lopez Rodriguez E; Jonigk D; Kühnel MP; DeLuca D; Prasse A; Welte T; Gauldie J; Kolb MR; Maus UA
Thorax; 2019 Oct; 74(10):947-957. PubMed ID: 31076499
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cell homeostasis is maintained by nonhematopoietic and T-cell-produced Flt3-ligand in steady state and during immune responses.
Saito Y; Boddupalli CS; Borsotti C; Manz MG
Eur J Immunol; 2013 Jun; 43(6):1651-8. PubMed ID: 23519969
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2-mediated inhibition of dendritic cell development correlates with decreased CD135 expression and increased monocyte/macrophage precursors.
Guerrero AD; Dong MB; Zhao Y; Lau-Kilby A; Tarbell KV
Immunology; 2014 Dec; 143(4):640-50. PubMed ID: 24954893
[TBL] [Abstract][Full Text] [Related]
20. Expansion of peripheral naturally occurring T regulatory cells by Fms-like tyrosine kinase 3 ligand treatment.
Swee LK; Bosco N; Malissen B; Ceredig R; Rolink A
Blood; 2009 Jun; 113(25):6277-87. PubMed ID: 19211508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
